- This event has passed.
Top Medical Breakthroughs from the San Antonio Breast Cancer Symposium
This webinar will explore key research breakthroughs presented at the San Antonio Breast Cancer Symposium (SABCS), which is an annual international scientific conference focused on the latest research in breast cancer. Our expert speaker Dr. Reva Basho will translate complex findings into clear, accessible insights. She’ll highlight what’s new, what’s promising, and what these advances mean for patients, families, and clinicians.
Bonus for our Embrace Community: We invite members of our Embrace community, those facing metastatic breast or advanced ovarian cancer, to stay on at the end of the webinar for an intimate breakout session with our speaker and Bonnie Beckoff, Director of Sharsheret Support Services.
For more information contact Bonnie Beckoff at [email protected].
Embrace Breakout session sponsored by 
Speaker Bio:
Dr. Reva Basho is a breast medical oncologist and clinical investigator. She is an Associate Professor of Medicine and currently serves as the Chief Medical Officer at the Ellison Medical Institute.
Dr. Basho received her undergraduate training at Rice University and her medical degree from Baylor College of Medicine. She completed her Internal Medicine residency at UCLA Medical Center and her Hematology and Oncology fellowship at MD Anderson Cancer Center.
Alongside her clinical practice, Dr. Basho is a respected and nationally-recognized clinical investigator. Her research focuses on the development of novel therapies for the treatment of breast cancer. As an investigator, she has served as the PI of numerous clinical trials, serves on several steering committees for international phase 3 clinical trials, and is currently leading a sub-study of the National Cancer Institute’s ComboMATCH trial.
Dr. Basho has authored many research articles, book chapters, and abstracts. She is active in national organizations including the American Society of Clinical Oncology, American Association for Cancer Research, and the Southwest Oncology Group. She has previously served as a member of the National Cancer Institute’s working group for neoadjuvant clinical endpoints. Dr. Basho is also passionate about mentoring medical students and trainees.